Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis
Clinical and Applied Thrombosis/Hemostasis · 2024-01 · 30
DOI: 10.1177/10760296241279293 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 09.09.2024. Verfasst von Yan Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Venous Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Health Commission of Zhejiang Province, China.
Abstract (Originalsprache)
This study investigates the prevalence and risk factors associated with venous thrombotic events in patients receiving (ECMO) support. Systematic review and meta-analysis of case-control and cohort studies. PubMed, Cochrane Library, Embase, CINAHL, Web of Science, Scopus, and ProQuest databases from inception through November 25, 2023.Case-control and cohort studies focusing on the prevalence and risk factors for venous thrombotic events in patients supported by ECMO. Identification of risk factors and calculation of incidence rates. Nineteen studies encompassing 10,767 participants were identified and included in the analysis. The pooled prevalence of venous thrombotic events among patients receiving ECMO support was 48% [95% confidence interval (CI) 0.37–0.60, I 2 = 97.18%]. Factors associated with increased incidence rates included longer duration of ECMO support (odds ratio [OR] 1.08, 95% CI 1.07-1.09, I 2 = 49%), abnormal anti-coagulation monitoring indicators (OR 1.02, 95% CI 1.00-1.04, I 2 = 84%), and type of ECMO cannulation (OR 1.77, 95% CI 1.14-3.34, I 2 = 64%). The pooled prevalence of venous thrombotic events in patients with ECMO support is high. Increased risk is associated with extended duration of ECMO support, abnormal anti-coagulation monitoring, and specific types of ECMO cannulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Fei Zeng
Förderung
- the Health Commission of Zhejiang Province, China
Zitieren
APA
Zhu, Y., Lan, M. J., Liang, J. S., Cai, L. Y., Guo, L. Y., Gu, P. P., & Zeng, F. (2024). Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis, 30. https://doi.org/10.1177/10760296241279293
Vancouver
Zhu Y, Lan MJ, Liang JS, Cai LY, Guo LY, Gu PP, et al. Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis. 2024;30. doi:10.1177/10760296241279293
BibTeX
@article{Zhu2024,
author = {Zhu, Yan and Lan, Mei-Juan and Liang, Jiang-Shu-Yuan and Cai, Ling-Yun and Guo, Lu-Yao and Gu, Pei-Pei and Zeng, Fei},
title = {Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2024},
volume = {30},
doi = {10.1177/10760296241279293}
}
EUVIMED